Varied Sensitivity to Therapy of HIV-1 Strains in CD4+ Lymphocyte Sub-populations Upon ART Initiation

Overview

Journal AIDS Res Ther

Publisher Biomed Central

Specialty Infectious Diseases

Date 2010 Dec 8

PMID 21134247

Citations 3

Authors

Edwin J Heeregrave

Mark J Geels

Elly Baan

Renee M van der Sluis

William A Paxton

Georgios Pollakis

Affiliations

Soon will be listed here.

Abstract

Background: Although antiretroviral therapy (ART) has proven its success against HIV-1, the long lifespan of infected cells and viral latency prevent eradication. In this study we analyzed the sensitivity to ART of HIV-1 strains in naïve, central memory and effector memory CD4+ lymphocyte subsets.

Methods: From five patients cellular HIV-1 infection levels were quantified before and after initiation of therapy (2-5 weeks). Through sequencing the C2V3 region of the HIV-1 gp120 envelope, we studied the effect of short-term therapy on virus variants derived from naïve, central memory and effector memory CD4+ lymphocyte subsets.

Results: During short-term ART, HIV-1 infection levels declined in all lymphocyte subsets but not as much as RNA levels in serum. Virus diversity in the naïve and central memory lymphocyte populations remained unchanged, whilst diversity decreased in serum and the effector memory lymphocytes. ART differentially affected the virus populations co-circulating in one individual harboring a dual HIV-1 infection. Changes in V3 charge were found in all individuals after ART initiation with increases within the effector memory subset and decreases found in the naïve cell population.

Conclusions: During early ART virus diversity is affected mainly in the serum and effector memory cell compartments. Differential alterations in V3 charge were observed between effector memory and naïve populations. While certain cell populations can be targeted preferentially during early ART, some virus strains demonstrate varied sensitivity to therapy, as shown from studying two strains within a dual HIV-1 infected individual.

Citing Articles

Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.

Puertas M, Noguera-Julian M, Massanella M, Pou C, Buzon M, Clotet B Retrovirology. 2016; 13(1):51.

PMID: 27484989 PMC: 4970251. DOI: 10.1186/s12977-016-0282-9.

High CCR5 density on central memory CD4+ T cells in acute HIV-1 infection is mostly associated with rapid disease progression.

Yang X, Jiao Y, Wang R, Ji Y, Zhang H, Zhang Y PLoS One. 2012; 7(11):e49526.

PMID: 23185351 PMC: 3504013. DOI: 10.1371/journal.pone.0049526.

Analysis of multiple cell reservoirs expressing unspliced HIV-1 gag-pol mRNA in patients on antiretroviral therapy.

Shults K, Flye-Blakemore L, Patterson B, Elbeik T Future Virol. 2012; 7(8):819-832.

PMID: 23125871 PMC: 3486786. DOI: 10.2217/fvl.12.69.

References

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, OSullivan M . Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994; 331(18):1173-80. DOI: 10.1056/NEJM199411033311801. View

Baldanti F, Paolucci S, Gulminetti R, Maserati R, Migliorino G, Pan A . Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART. Antiviral Res. 2001; 50(3):197-206. DOI: 10.1016/s0166-3542(01)00142-5. View

Schutten M, van der Ende M, Osterhaus A . Antiretroviral therapy in patients with dual infection with human immunodeficiency virus types 1 and 2. N Engl J Med. 2000; 342(23):1758-60. DOI: 10.1056/NEJM200006083422317. View

Heeregrave E, Geels M, Brenchley J, Baan E, Ambrozak D, van der Sluis R . Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets. Virology. 2009; 393(1):24-32. PMC: 2753733. DOI: 10.1016/j.virol.2009.07.011. View

Sahu G, Paar D, Frost S, Smith M, Weaver S, Cloyd M . Low-level plasma HIVs in patients on prolonged suppressive highly active antiretroviral therapy are produced mostly by cells other than CD4 T-cells. J Med Virol. 2008; 81(1):9-15. PMC: 2912142. DOI: 10.1002/jmv.21366. View

Brenchley J, Hill B, Ambrozak D, Price D, Guenaga F, Casazza J . T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol. 2004; 78(3):1160-8. PMC: 321406. DOI: 10.1128/jvi.78.3.1160-1168.2004. View

Ostrowski M, Chun T, Justement S, Motola I, SPINELLI M, Adelsberger J . Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals. J Virol. 1999; 73(8):6430-5. PMC: 112723. DOI: 10.1128/JVI.73.8.6430-6435.1999. View

Schols D, Este J, Cabrera C, De Clercq E . T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use. J Virol. 1998; 72(5):4032-7. PMC: 109631. DOI: 10.1128/JVI.72.5.4032-4037.1998. View

Groot F, van Capel T, Schuitemaker J, Berkhout B, de Jong E . Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission. Retrovirology. 2006; 3:52. PMC: 1562438. DOI: 10.1186/1742-4690-3-52. View

10.

Delobel P, Sandres-Saune K, Cazabat M, LFaqihi F, Aquilina C, Obadia M . Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS. 2005; 19(16):1739-50. DOI: 10.1097/01.aids.0000183125.93958.26. View

11.

Kinter A, Moorthy A, Jackson R, Fauci A . Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents. AIDS Res Hum Retroviruses. 2003; 19(10):847-56. DOI: 10.1089/088922203322493012. View

12.

Denton P, Estes J, Sun Z, Othieno F, Wei B, Wege A . Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med. 2008; 5(1):e16. PMC: 2194746. DOI: 10.1371/journal.pmed.0050016. View

13.

Mallon P . Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy. AIDS Rev. 2007; 9(1):3-15. View

14.

Geeraert L, Kraus G, Pomerantz R . Hide-and-seek: the challenge of viral persistence in HIV-1 infection. Annu Rev Med. 2007; 59:487-501. DOI: 10.1146/annurev.med.59.062806.123001. View

15.

Brennan T, Woods J, Sedaghat A, Siliciano J, Siliciano R, Wilke C . Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol. 2009; 83(17):8470-81. PMC: 2738142. DOI: 10.1128/JVI.02568-08. View

16.

Eckstein D, Penn M, Korin Y, Zack J, Kreisberg J, Roederer M . HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity. 2001; 15(4):671-82. DOI: 10.1016/s1074-7613(01)00217-5. View

17.

Ince W, Harrington P, Schnell G, Patel-Chhabra M, Burch C, Menezes P . Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. J Virol. 2009; 83(9):4068-80. PMC: 2668457. DOI: 10.1128/JVI.02486-08. View

18.

Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio F, Yassine-Diab B . HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med. 2009; 15(8):893-900. PMC: 2859814. DOI: 10.1038/nm.1972. View

19.

Westermann J, Pabst R . Distribution of lymphocyte subsets and natural killer cells in the human body. Clin Investig. 1992; 70(7):539-44. DOI: 10.1007/BF00184787. View

20.

van der Kuyl A, Cornelissen M . Identifying HIV-1 dual infections. Retrovirology. 2007; 4:67. PMC: 2045676. DOI: 10.1186/1742-4690-4-67. View